Press Release U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse 16 hours ago
Press Release Health Optimization & Longevity Arrives in Boulder: Next Health Celebrates Grand Opening with Live Podcast Recording Featuring Dr. Darshan Shah and Ben Greenfield 18 hours ago
Press Release flyExclusive Reports Record Second Quarter Revenue and Third Consecutive Quarter of Positive Adjusted EBITDA 18 hours ago
Press Release Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results 18 hours ago
Press Release Savers Value Village, Inc. Announces Closing of Upsized Secondary Public Offering of Common Stock and Concurrent Share Repurchase 19 hours ago